Enrolling by invitationNCT05609201

PRospective Evaluation of Interstitial Lung DIsease Progression With Quantitative CT

Studying Interstitial lung disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Exeter
Principal Investigator
Giles Dixon
University of Exeter
Intervention
HRCT Thorax(diagnostic_test)
Enrollment
54 target
Eligibility
18-85 years · All sexes
Timeline
2023 – 2024

Study locations (1)

Collaborators

North Bristol NHS Trust · Royal United Hospitals Bath NHS Foundation Trust · Royal Devon and Exeter NHS Foundation Trust

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05609201 on ClinicalTrials.gov

Other trials for Interstitial lung disease

Additional recruiting or active studies for the same condition.

See all trials for Interstitial lung disease →

← Back to all trials